The uncoupling of race and cancer genetics

Cancer

Volumn 83, Issue 8 SUPPL., 1998, Pages 1765-1769

  Liu, Edison T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER GENETICS; CANCER MORTALITY; CANCER STAGING; CONFERENCE PAPER; ECONOMIC ASPECT; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIOECONOMICS; TREATMENT OUTCOME;

EID: 0032531920     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19981015)83:8+<1765::aid-cncr19>3.0.co;2-4     Document Type: Conference Paper

References (12)

1. Chen VW, Correa Y, Kurman RJ, Wu XC, Eley JW, Austin D, Muss H, Hunter CP, Redmend C, Sobhan M, Coates R, Reynolds P, Herman AA, Edwards BK. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biol Prevent 1994;3:127-35.
2. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, hispanic, and black women in the United States. J Natl Cancer Inst 1994;86(9):705-12.
3. Gapstur SM, Dupuis J, Gann P, Collila S, Winchester DP. Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. Cancer 1996;77(8):1465-71.
4. Perkins P, Cooksley CD, Cox JD. Breast cancer: is ethnicity an independent prognostic factor for survival? Cancer 1996; 78(6):1241-7.
5. Eley W, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, Greenberg RS, Coates RJ, Correa P, Redmond CK, Hunter CP, Herman AA, Kurman R, Blacklow R, Shapiro S, Edwards B. Racial differences in survival from breast cancer. JAMA 1994;272(12):947-54.
6. Shiao YH, Chen VW, Cheer WD, Wu XC, Correa P. Racial disparity in the association of p53 gene alterations with breast cancer. Cancer Res 1995;55:1485-90.
7. Thor AD, Berry DA, Budman DR, Muss HB, Kute T, Henderson IC, Barcos M, Cirrincione C, Edgerton S, Allred C, Norton L, Liu ET. Role of erbB-2 and p53 in modulating the efficacy of adjuvant therapy in node positive breast cancer. JNCI. Submitted.
8. Roach M, Cirrincione C, Budman D, Hayes D, Berry D, Younger J, Hart R, Henderson IC. Race and survival from breast cancer: based on Cancer and Leukemia Group B Trial 8541. Cancer J Sci Am 1997;3(2):107-12.
9. Fitzgerald MG, MacDonald DJ, Krainer M, et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 1996;334: 143-9.
10. Offit K, Gilewski T, McGuire P, et al. Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 1996;347:1643-5.
11. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, et al. Studies of the HER-2/ neu proto-oncogene in human breast and ovarian cancer. Science 1989;244(4905):707-12.
12. Muss HB, Thor AD, Berry DA, et al. c-erbB-2 Expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 1994;330:1260-6.